| scholarly article | Q13442814 |
| P50 | author | Massimo Negrini | Q28324645 |
| Manuela Ferracin | Q28324648 | ||
| Katia Scotlandi | Q57069898 | ||
| Maria Cristina Manara | Q63869904 | ||
| Selena Ventura | Q75839827 | ||
| Sakari Knuutila | Q89126067 | ||
| Marco Alberghini | Q117248739 | ||
| Massimo Serra | Q38549348 | ||
| Piero Picci | Q40240179 | ||
| Gianfranco Mattia | Q47784879 | ||
| P2093 | author name string | Stefano Ferrari | |
| Andrea Grilli | |||
| Karl-Ludwig Schaefer | |||
| Valentina Del Monaco | |||
| Fumihiko Nakatani | |||
| P2860 | cites work | Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence | Q24650175 |
| Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy | Q24651380 | ||
| Semi-supervised methods to predict patient survival from gene expression data | Q24804682 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The miR-34 family in cancer and apoptosis | Q28245865 | ||
| Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma | Q28284358 | ||
| Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 | ||
| MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells | Q28287986 | ||
| Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 | ||
| A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
| Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 | ||
| MiR-34a and p53. | Q48490724 | ||
| Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol | Q56985814 | ||
| The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts | Q57756648 | ||
| MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells | Q33497932 | ||
| Mesenchymal stem cell features of Ewing tumors | Q34003979 | ||
| Micromarkers: miRNAs in cancer diagnosis and prognosis. | Q34108602 | ||
| Mechanisms of sarcoma development | Q35210018 | ||
| Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues | Q36575667 | ||
| Unique MicroRNA signature and clinical outcome of cancers | Q36822466 | ||
| p53 enters the microRNA world | Q36998341 | ||
| The guardian's little helper: microRNAs in the p53 tumor suppressor network | Q37023130 | ||
| Bone and soft tissue sarcomas are often curable--but at what cost?: a call to arms (and legs). | Q37577843 | ||
| MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types | Q37641491 | ||
| miRNAs as molecular biomarkers of cancer | Q37750843 | ||
| Approaching Ewing sarcoma | Q37771959 | ||
| Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors | Q38346476 | ||
| Nutlin-3a is a potential therapeutic for ewing sarcoma | Q39628701 | ||
| EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells | Q39716224 | ||
| Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort | Q39793825 | ||
| Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples | Q39820788 | ||
| Identification of cancer stem cells in Ewing's sarcoma | Q39885066 | ||
| Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells | Q39932777 | ||
| Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy | Q40009768 | ||
| Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. | Q40318247 | ||
| Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse | Q45230556 | ||
| Power and sample size calculations for studies involving linear regression | Q47273484 | ||
| P433 | issue | 5 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 796-805 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | |
| P478 | volume | 226 |
| Q64117030 | An Insight into the Roles of MicroRNAs and Exosomes in Sarcoma |
| Q21198840 | An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma |
| Q42131196 | Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. |
| Q37499995 | Association of circulating miR-125b and survival in patients with osteosarcoma-A single center experience |
| Q36758011 | Biomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges. |
| Q36907188 | Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group. |
| Q42392077 | CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling |
| Q26777117 | Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts |
| Q33615709 | Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| Q39121566 | Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma |
| Q45226908 | Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. |
| Q33761531 | Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models |
| Q91783111 | Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients |
| Q35131440 | Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. |
| Q35987417 | Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine |
| Q38680431 | Epigenetic alternations and cancer chemotherapy response |
| Q38964936 | Epigenetic and genetic changes in soft tissue sarcomas: a review |
| Q38209574 | Epigenetic perspectives on cancer chemotherapy response |
| Q56609038 | Ewing sarcoma |
| Q34997023 | First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). |
| Q38102553 | Friend or foe: the role of microRNA in chemotherapy resistance |
| Q34702270 | Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma |
| Q35496606 | Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer |
| Q34764399 | Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells |
| Q92987609 | MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues |
| Q37692351 | MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene |
| Q37317570 | MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene |
| Q50027412 | MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1. |
| Q38296481 | MicroRNA expression and its clinical implications in Ewing's sarcoma |
| Q37473350 | MicroRNA function and dysregulation in bone tumors: the evidence to date |
| Q90480815 | MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression |
| Q35763174 | MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy |
| Q35030251 | MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44 |
| Q39124552 | MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment |
| Q27003249 | MicroRNA-34a: a potential therapeutic target in human cancer |
| Q38743265 | MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1. |
| Q38837784 | MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma |
| Q38038076 | MicroRNA-mediated gene regulations in human sarcomas |
| Q28087258 | MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics |
| Q90464161 | MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index |
| Q58923813 | MicroRNAs in Cancer Drug Resistance and Drug Sensitivity |
| Q36722134 | MicroRNAs in Ewing Sarcoma |
| Q27006159 | MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers |
| Q58792269 | MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1 |
| Q38253374 | Mir-34: a new weapon against cancer? |
| Q37719938 | Molecular mechanisms of chemoresistance in osteosarcoma (Review). |
| Q90733316 | Non-Coding RNAs in Pediatric Solid Tumors |
| Q41924654 | Noncoding RNA in drug resistant sarcoma |
| Q50148274 | Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2. |
| Q33437383 | Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors |
| Q38740584 | Poly r(C) binding protein (PCBP) 1 expression is regulated at the post-translation level in thyroid carcinoma |
| Q37228032 | Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma |
| Q51506668 | Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma. |
| Q36531823 | Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy |
| Q36411504 | Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients |
| Q50658268 | Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. |
| Q26801785 | Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes |
| Q50678236 | The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis. |
| Q90249624 | The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug |
| Q38108248 | The adolescent and young adult with cancer: state of the art -- bone tumors |
| Q38385755 | The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients |
| Q35993560 | The first European interdisciplinary ewing sarcoma research summit |
| Q39041044 | The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma |
| Q36245752 | The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene |
| Q36845699 | The orphan nuclear receptor NR4A2 is part of a p53-microRNA-34 network |
| Q36111707 | The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis |
| Q38001369 | The roles of microRNAs in sarcomas |
| Q26768602 | Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting |
| Q38182423 | Therapy resistance mechanisms in Ewing's sarcoma family tumors |
| Q37376411 | Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma. |
| Q26829949 | Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression |
| Q26800124 | What Do We Know about the Role of miRNAs in Pediatric Sarcoma? |
| Q91591260 | [Plasma miRNA-23a and miRNA-451 as candidate biomarkers for early diagnosis of nonsmall cell lung cancer: a case-control study] |
| Q41051759 | miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor |
| Q40106559 | miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma |
| Q47615336 | miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal |
| Q38972595 | miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression |
| Q36596220 | miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3) |
| Q61760942 | miRNA-Targeted Therapies in the Most Prevalent Pediatric Solid Tumors |
| Q38667026 | microRNA and Bone Cancer |
| Q90706419 | microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance |
| Q30409530 | microRNA-34a promotes DNA damage and mitotic catastrophe. |
Search more.